What’s the number one cause of blindness in people over age 60 living in Europe and North America? The answer is age-related macular degeneration, or AMD, which currently
Angiogenesis, the process of new blood vessel formation, is essential for tumor growth and progression, and blocking this process has emerged as an attractive approach to cancer therapy.